Blar i NTNU Open på forfatter "Ellekjær, Hanne"
-
The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort study
Thingstad, Pernille; Askim, Torunn; Beyer, Mona K.; Bråthen, Geir; Ellekjær, Hanne; Ihle-Hansen, Hege; Knapskog, Anne Brita; Lydersen, Stian; Munthe-Kaas, Ragnhild; Næss, Halvor; Pendlebury, Sarah; Seljeseth, Yngve Müller; Saltvedt, Ingvild (Journal article; Peer reviewed, 2018)Background Early and late onset post-stroke cognitive impairment (PCI) contributes substantially to disability following stroke, and is a high priority within stroke research. The aetiology for PCI is complex and related ... -
Transient ischemic attack (TIA) – Assessment of stroke risk and use of risk evaluation tools after TIA: The MIDNOR TIA study
Ildstad, Fredrik (Doctoral theses at NTNU;2022:19, Doctoral thesis, 2022)NORSK SAMMENDRAG: Transitorisk iskemisk anfall (TIA) – Risiko for hjerneslag og bruk av kliniske og biologiske markører for vurdering av risiko Årlig rammes ca. 12 000 mennesker i Norge av hjerneslag. Det finnes et vidt ... -
Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015
Kjerpeseth, Lars Jøran; Ellekjær, Hanne; Selmer, Randi; Ariansen, Inger Kristine; Furu, Kari; Skovlund, Eva (Journal article; Peer reviewed, 2017)Purpose Since 2011, several direct oral anticoagulants (DOACs; dabigatran, rivaroxaban, apixaban) have been introduced as alternatives to warfarin for stroke prophylaxis in atrial fibrillation. We wanted to investigate ... -
Trondheim Early Neurological Deterioration study Detection and predictors of Early Neurological Deterioration after ischemic stroke
Helleberg, Bernt Harald (Doctoral theses at NTNU;2018:48, Doctoral thesis, 2018)In 2015, 11000 patients were treated in Norwegian hospitals with stroke as their primary diagnosis. This number may increase substantially over the next decades due to more elderly and very old people in the population. ... -
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
Gynnild, Mari Nordbø; Hageman, Steven H. J.; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN; Visseren, Frank L.J.; Ellekjær, Hanne (Peer reviewed; Journal article, 2022)Objectives: Elevated low-density lipoprotein cholesterol (LDL-C) increases the risk of recurrent cardiovascular disease (CVD) events. We examined use of lipid-lowering therapy (LLT) following ischaemic stroke, and estimated ... -
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
Gynnild, Mari Nordbø; Hageman, Steven H. J.; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN; Visseren, Frank L.J.; Ellekjær, Hanne (Journal article; Peer reviewed, 2022) -
Validation of self-reported and hospital-diagnosed atrial fibrillation: The HUNT study
Malmo, Vegard; Langhammer, Arnulf; Bønaa, Kaare; Loennechen, Jan Pål; Ellekjær, Hanne (Journal article; Peer reviewed, 2016)Background: Self-reported atrial fibrillation (AF) and diagnoses from hospital registers are often used to identify persons with AF. The objective of this study was to validate self-reported AF and hospital discharge ... -
Vascular risk factor control and adherence to secondary preventive medication after ischemic stroke
Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Askim, Torunn; Beyer, Mona Kristiansen; Ihle-Hansen, Hege; Munthe-Kaas, Ragnhild; Knapskog, Anne Brita; Lydersen, Stian; Næss, Halvor; Røsstad, Tove Garåsen; Seljeseth, Yngve Müller; Thingstad, Pernille; Saltvedt, Ingvild; Ellekjær, Hanne (Peer reviewed; Journal article, 2020)Background Studies regarding adequacy of secondary stroke prevention are limited. We report medication adherence, risk factor control and factors influencing vascular risk profile following ischaemic stroke. Methods A ...